BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35032114)

  • 1. The association of obesity with thyroid carcinoma risk.
    Ma XN; Ma CX; Hou LJ; Fu SB
    Cancer Med; 2022 Feb; 11(4):1136-1144. PubMed ID: 35032114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and thyroid cancer: a clinical update.
    Pappa T; Alevizaki M
    Thyroid; 2014 Feb; 24(2):190-9. PubMed ID: 23879222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and Thyroid Cancer Risk: An Update.
    Franchini F; Palatucci G; Colao A; Ungaro P; Macchia PE; Nettore IC
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity as a risk factor for thyroid cancer.
    Matrone A; Ferrari F; Santini F; Elisei R
    Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):358-363. PubMed ID: 32740043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and the prevention of thyroid cancer: Impact of body mass index and weight change on developing thyroid cancer - Pooled results of 24 million cohorts.
    Youssef MR; Reisner ASC; Attia AS; Hussein MH; Omar M; LaRussa A; Galvani CA; Aboueisha M; Abdelgawad M; Toraih EA; Randolph GW; Kandil E
    Oral Oncol; 2021 Jan; 112():105085. PubMed ID: 33171329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and thyroid cancer.
    Mijovic T; How J; Payne RJ
    Front Biosci (Schol Ed); 2011 Jan; 3(2):555-64. PubMed ID: 21196396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attributable risk fraction of four lifestyle risk factors of thyroid cancer: a meta-analysis.
    Sadeghi H; Rafei M; Bahrami M; Haghdoost A; Shabani Y
    J Public Health (Oxf); 2018 Jun; 40(2):e91-e98. PubMed ID: 28977647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies.
    Zhao ZG; Guo XG; Ba CX; Wang W; Yang YY; Wang J; Cao HY
    J Int Med Res; 2012; 40(6):2041-50. PubMed ID: 23321160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies.
    Xu L; Port M; Landi S; Gemignani F; Cipollini M; Elisei R; Goudeva L; Müller JA; Nerlich K; Pellegrini G; Reiners C; Romei C; Schwab R; Abend M; Sturgis EM
    Thyroid; 2014 Jun; 24(6):966-74. PubMed ID: 24555500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Overweight and Obesity on US Papillary Thyroid Cancer Incidence Trends (1995-2015).
    Kitahara CM; Pfeiffer RM; Sosa JA; Shiels MS
    J Natl Cancer Inst; 2020 Aug; 112(8):810-817. PubMed ID: 31638139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms.
    Pazaitou-Panayiotou K; Polyzos SA; Mantzoros CS
    Obes Rev; 2013 Dec; 14(12):1006-22. PubMed ID: 24034423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of thyroid cancer and obesity: A nationwide population-based study using the Korea National Health Insurance Corporation cohort database.
    Son H; Lee H; Kang K; Lee I
    Surg Oncol; 2018 Jun; 27(2):166-171. PubMed ID: 29937167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population.
    Han JM; Kim TY; Jeon MJ; Yim JH; Kim WG; Song DE; Hong SJ; Bae SJ; Kim HK; Shin MH; Shong YK; Kim WB
    Eur J Endocrinol; 2013 Jun; 168(6):879-86. PubMed ID: 23513231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency.
    Burgess JR; Dwyer T; McArdle K; Tucker P; Shugg D
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1513-7. PubMed ID: 10770190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthropometric Risk Factors for Differentiated Thyroid Cancer in Young Men and Women From Eastern France: A Case-Control Study.
    Xhaard C; de Vathaire F; Cléro E; Maillard S; Ren Y; Borson-Chazot F; Sassolas G; Schvartz C; Colonna M; Lacour B; Danzon A; Velten M; Marrer E; Bailly L; Barjoan EM; Schlumberger M; Orgiazzi J; Adjadj E; Rubino C
    Am J Epidemiol; 2015 Aug; 182(3):202-14. PubMed ID: 26133374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized.
    Steinhagen E; Guillem JG; Chang G; Salo-Mullen EE; Shia J; Fish S; Stadler ZK; Markowitz AJ
    Clin Colorectal Cancer; 2012 Dec; 11(4):304-8. PubMed ID: 22425061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid cancers potentially preventable by reducing overweight and obesity in Australia: A pooled cohort study.
    Laaksonen MA; MacInnis RJ; Canfell K; Shaw JE; Magliano DJ; Banks E; Giles GG; Byles JE; Gill TK; Mitchell P; Hirani V; Cumming RG; Vajdic CM
    Int J Cancer; 2022 Apr; 150(8):1281-1290. PubMed ID: 34847246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review of Trends in the Incidence Rates of Thyroid Cancer.
    Wiltshire JJ; Drake TM; Uttley L; Balasubramanian SP
    Thyroid; 2016 Nov; 26(11):1541-1552. PubMed ID: 27571228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Prevalence of Thyroid Cancer Over Three Decades: A Retrospective Cohort Study of 17,526 Surgical Patients.
    Konturek A; Barczyński M; Stopa M; Nowak W
    World J Surg; 2016 Mar; 40(3):538-44. PubMed ID: 26560150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Fundamental Mechanisms of Thyroid Cancer.
    Prete A; Borges de Souza P; Censi S; Muzza M; Nucci N; Sponziello M
    Front Endocrinol (Lausanne); 2020; 11():102. PubMed ID: 32231639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.